Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jun 15, 2022 10:37am
$6.00 us price target $7.76 cdn
Brookline Capital Markets Sticks to Its Buy Rating for Antibe Therapeutics (ATBPF) Howard KimMay 04, 2022, 12:35 AM In a report issued on May 2, Kemp Dolliver
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jun 15, 2022 10:14am
RE:RE:RE:Warrant extension
i am ok with $180+ in 18 months or less from now. if you have loaded up down here you will do fine.
(2)
•••
Doccole
X
View Profile
View Bullboard History
Comment by
Doccole
on Jun 15, 2022 9:58am
RE:RE:Warrant extension
If our stock price is 1.80 in 2023, fail. I am hoping for more than that. i am hoping for a big rebound going into phase 2 with some progress updates.
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jun 15, 2022 9:36am
Looks Like
the street agrees with me. and once again pez missed the boat do to his zzzzzzzzzzzzz LMAO
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jun 15, 2022 9:33am
My Guess
management thinks the warrants will be in the money before the new expiration date, helps company for re-financing
(55)
•••
StockingUp21
X
View Profile
View Bullboard History
Comment by
StockingUp21
on Jun 15, 2022 9:28am
RE:Warrant extension
Mayne look at other businesses that have done the same thing. If I had a guess...
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jun 15, 2022 9:27am
Relevant Information
Why would a company extend warrant? "); display: inline-block; height: 24px; width: 24px; margin-top: -1px; transform: rotateZ(-180deg);">
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jun 15, 2022 9:23am
Relevant information
Why would a company extend warrants? "); display: inline-block; height: 24px; width: 24px; margin-top: -1px; transform: rotateZ(-180deg);">
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Jun 15, 2022 9:10am
Pez S.T.F.U.
do you ever have anything inteligent to add, like maybe relevant thoughts on the warrants for example. all your posts are attack posts, you add 0 to the board. if you do not like what i post that is
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jun 15, 2022 7:56am
RE:Warrant extension
Renegotiated pricing on the warrant in order to still be able to bring in some cash before 2024. Probably wise to have that stream of cash available as ATE will be burning through cash. The
...more
(33)
•••
Inthepez
X
View Profile
View Bullboard History
Comment by
Inthepez
on Jun 15, 2022 7:27am
RE:RE:RE:Big Red Day
let us know when you predictions are actually ever right. so far, your comments have gone largely ignored and add zero value to the board. Most have realized what a useless contributor you are. Makes
...more
(2)
•••
Doccole
X
View Profile
View Bullboard History
Post by
Doccole
on Jun 15, 2022 7:13am
Warrant extension
What will this mean for the stock price? What / if any significance does this news bring? thanks for thoughts!
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 15, 2022 7:00am
New Press Release - Antibe Therapeutics Announces Amendment to Warrant Terms
Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF) (the "Company"), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, announces that it is extending the expiry date (the “Warrant Extension”) and amending the...
read article.
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jun 15, 2022 6:19am
RE:Not even interested in 5000 shares for .65 cents eh mugsy
Come on you must know, mugsy's wealth is up in the tens of thousands of penies given the profits he made in the last 8 years
(81)
•••
Stutters
X
View Profile
View Bullboard History
Post by
Stutters
on Jun 14, 2022 10:07pm
Not even interested in 5000 shares for .65 cents eh mugsy
https://youtu.be/QuKBsJoA7jk
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >